Relationship of residual beta-cell function, metabolic control and chronic complications in type 2 diabetes mellitus

Acta Diabetologica

Volumn 37, Issue 3, 2000, Pages 125-129

  Bo, S ^a   Cavallo Perin, P ^a   Gentile, L ^b   Repetti, E ^b   Pagano, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Hospital of Asti   (Italy)

Author keywords

C peptide; Chronic complications; Metabolic syndrome; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; C PEPTIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; ALBUMINURIA; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; ISLETS OF LANGERHANS; ITALY; LOGISTIC MODELS; MALE; TRIGLYCERIDES; URIC ACID;

EID: 0034485456     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920070014     Document Type: Article

References (31)

1. Metabolic evolution of type 2 diabetes: A 10-year follow-up from the diagnosis
2. C-peptide in NIDDM. Follow-up for 4-6 years
3. Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden
4. The KID study V: The natural history of type 2 diabetes in younger patients still practicing a profession. Heterogeneity of basal and reactive C-peptide in relation to BMI, duration of disease, age and HbA1
5. Lilly lecture 1994. The β-cell in diabetes: From molecular genetics to clinical research
6. Circulating C-peptide and diabetic retinopathy
7. High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity
8. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type 2 diabetes mellitus
9. The effect of residual beta-cell function on the development of diabetic retinopathy
10. Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes
11. The Wisconsin epidemiologic study of diabetic retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy
12. Control of non-insulin dependent diabetes is not correlated with endogenous insulin secretion
13. Home blood glucose monitoring, glycosylated hemoglobin and fructosamine; their relationships in diabetic patients with and without residual C-peptide secretion
14. Sex and BMI-related difference in risk factors for coronary artery disease in patients with type 2 diabetes mellitus
15. Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes
16. A population-based prevalence survey of known diabetes mellitus in Northern Italy based upon multiple independent sources of ascertainment
17. The endogenous insulin secretion was suppressed during insulin therapy in NIDDM patients
18. Variation of endogenous insulin secretion in association with treatment status: Assessment by serum C-peptide and modified urinary C-peptide
19. A protocol for screening for diabetic retinopathy in Europe
20. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
21. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure
22. Relationship of C-peptide levels and C-peptide/blood sugar ratio with clinical/biochemical variables associated with insulin resistance in orally-treated, well controlled type 2 diabetic patients
23. Blood pressure, insulin and C-peptide levels in San Luis Valley, Colorado
24. Role of insulin resistance in human disease
25. Relationship between beta-cell function and diabetic duration and albuminuria in type 2 diabetes mellitus
26. Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications
27. The Wisconsin epidemiologic study of diabetic retinopathy. XII. The relationship of C-peptide and diabetic retinopathy
28. Insulin secretion in the diagnosis of adult-onset diabetes mellitus
29. The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase
30. The classification of diabetes by clinical and C-peptide criteria